ArticleEuropean heart journal open2026

Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular and non-cardiovascular outcomes in patients at high/very-high cardiovascular risk without heart failure: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials

Stefano Masi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.